CancerNetwork®’s podcast hosted 2 experts to discuss the current state of biosimilar prescriptions and the need for change to improve the system overall.
Michael Kane, RPh, BCOP
Advertisement
Articles by Michael Kane, RPh, BCOP
Advertisement
Latest Updated Articles
Oncology Peer Review On-The-Go: BPCIA, 4-Letter Suffix Rule, & the Challenges of Prescribing BiosimilarsPublished: July 6th 2021 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Molecular Insights Into Cancer Cachexia: An Evolution in Identifying the Syndrome
2
FDA Grants Interchangeability Designation to 2 Denosumab Biosimilars
3
Sac-TMT Combo Produces Encouraging Activity in Pretreated Metastatic CRPC
4
AI-Powered Scout Platform Could Enhance Oncology Decision-Making With Data- and Expert-Driven Insights
5
